Provided by Tiger Trade Technology Pte. Ltd.

ACLARION, INC

2.61
-0.1000-3.69%
Volume:10K
Turnover:25.64K
Market Cap:7.52M
PE:-0.34
High:2.73
Open:2.73
Low:2.61
Close:2.71
52wk High:12.03
52wk Low:1.95
Shares:2.88M
Float Shares:2.62M
Volume Ratio:0.40
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.5967
EPS(LYR):-13.6087
ROE:-58.97%
ROA:-37.01%
PB:0.44
PE(LYR):-0.19

Loading ...

Company Profile

Company Name:
ACLARION, INC
Exchange:
NASDAQ
Establishment Date:
2008
Employees:
11
Office Location:
8181 Arista Place,Suite 100,Broomfield,Colorado,United States
Zip Code:
80021
Fax:
- -
Introduction:
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Directors

Name
Position
Brent Ness
Chief Executive Officer and Director and President
Jeff Thramann
Director and Executive Chairman
Amanda Williams
Director
David Neal
Director
Scott Breidbart
Director
Steve Deitsch
Director
William Wesemann
Director

Shareholders

Name
Position
Brent Ness
Chief Executive Officer and Director and President
Gregory Gould
Chief Financial Officer
Jeff Thramann
Director and Executive Chairman
Ryan Bond
Chief Strategy Officer